Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Therapeutic Advances in Respiratory Disease

• Publication date

  2009-10-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1753465809352791PMID 19880426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Observational studies: a review of study designs, challenges and strategies to reduce confounding

  2009cited by this paper
• Primary care spirometry*

  2008cited by this paper
• Geographic differences in clinical characteristics and management of COPD: the EPOCA study

  2008cited by this paper
• Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.

  2008cited by this paper
• Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare

  2008cited by this paper
• [Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement].

  2008cited by this paper
• [Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].

  2007cited by this paper
• Determining Factors in the Prescription of Moxifloxacin in Exacerbations of Chronic Bronchitis in the Primary-Care Setting

  2007cited by this paper
• International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

  2007cited by this paper
• Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD

  2007cited by this paper
• Review: Do we need new antibiotics for treating exacerbations of COPD?

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Use of spirometry and patterns of prescribing in COPD in primary care.

  2007cited by this paper
• Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study.

  2006cited by this paper
• Mexican American elders have similar severities of COPD despite less tobacco exposure than European American elders.

  2006cited by this paper
• Epidemiology and costs of chronic obstructive pulmonary disease

  2006influential reference
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study

  2006cited by this paper
• Chronic obstructive pulmonary disease: the disease and its burden to society.

  2006cited by this paper
• Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.

  2006cited by this paper
• Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

  2006cited by this paper
• Patient's perception of exacerbations of COPD--the PERCEIVE study.

  2006cited by this paper
• Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

  2005cited by this paper
• Guidelines for the management of adult lower respiratory tract infections

  2005cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease

  2005cited by this paper
• Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

  2005cited by this paper
• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

  2004cited by this paper
• [Epidemiology of chronic obstructive pulmonary disease].

  2004influential reference
• Daily-Practice Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin in a Large Cohort in Germany

  2004cited by this paper
• Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

  2004cited by this paper
• [Epidemiology of chronic obstructive pulmonary disease].

  2003cited by this paper
• Speed of Recovery from Acute Exacerbations of Chronic Obstructive Pulmonary Disease after Treatment with Antimicrobials

  2003cited by this paper
• Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

  2002influential reference
• Clinical Experience in Germany of Treating Community-Acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin

  2001influential reference
• Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

  2000cited by this paper
• Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis

  2000cited by this paper
• Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.

  2000influential reference
• Relation of FEV1 to Clinical Outcomes during Exacerbations of Chronic Obstructive Pulmonary Disease

  2000cited by this paper
• Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

  1998cited by this paper
• Why we need observational studies to evaluate the effectiveness of health care

  1996cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper
• Clinical Epidemiology Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article

  year unknowncited by this paper

• COPD_A_335742 3487..3502

  2021cites this paper
• Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study

  2021cites this paper
• Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies

  2021cites this paper
• QUALITY STATE OF LIPOPROTEINS IN PATHOLOGIES WITH DIFFERENT GENESIS

  2020cites this paper
• Within-host evolution of bovine Staphylococcus aureus selects for a SigB-deficient pathotype characterized by reduced virulence but enhanced proteolytic activity and biofilm formation

  2019cites this paper
• Патогенетичні аспекти лікування інфекційного гепатиту собак

  2019cites this paper
• Daily Symptom Variability in Patients With Stable COPD: A Narrative Review

  2018cites this paper
• Exacerbation of Bronchiectasis

  2017influential citation
• Pathogenetic aspects of virus-induced exacerbations of chronic bronchitis

  2017cites this paper
• ariability of Respiratory Symptoms in Severe COPD aría

  2017cites this paper
• Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.

  2016cites this paper
• JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy – The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG

  2016cites this paper
• Estimation Of Direct And Indirect Costs Associated With Asthma And Copd: A Canadian Employers Perspective

  2016cites this paper
• When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines

  2015cites this paper
• АЛГОРИТМ ДІАГНОСТИКИ ІНФЕКЦІЙНОГО ЗАГОСТРЕННЯ БРОНХІАЛЬНОЇ АСТМИ ВІРУСНОЇ ЕТІОЛОГІЇ

  2014cites this paper
• Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?

  2013cites this paper
• Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)

  2013cites this paper
• New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better?

  2013cites this paper
• Predictors of Adverse Outcome in Patients Hospitalised for Exacerbation of Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Variability of Respiratory Symptoms in Severe COPD

  2012cites this paper
• The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis

  2012cites this paper
• Usefulness of a patient symptom diary card in the monitoring of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

  2012cites this paper
• Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.

  2012cites this paper
• Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world

  2012cites this paper
• Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.

  2012cites this paper
• Variability of respiratory symptoms in severe COPD.

  2012cites this paper
• Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis

  2011cites this paper
• Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP study

  2010cites this paper
• Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study

  2010cites this paper
• Clinical Epidemiology Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article

  year unknowncites this paper